Literature DB >> 15869600

Altered cytoskeleton organization in platelets from patients with MYH9-related disease.

I Canobbio1, P Noris, A Pecci, A Balduini, C L Balduini, M Torti.   

Abstract

MYH9-related disease (MYH9-RD) is an autosomal dominant disorder deriving from mutations in the MYH9 gene encoding for the heavy chain of non-muscle myosin IIA, and characterized by thrombocytopenia and giant platelets. Isoform IIA of myosin is the only one expressed in platelets, but the possibility that MYH9 mutations affect the organization of contractile structures in these blood elements has never been investigated. In this work we have analyzed the composition and the agonist-induced reorganization of the platelet cytoskeleton from seven MYH9-RD patients belonging to four different families. We found that an increased amount of myosin was constitutively associated with actin in the cytoskeleton of resting MYH9-RD platelets. Upon platelet stimulation, an impaired increase in the total cytoskeletal proteins was observed. Moreover, selected membrane glycoproteins, tyrosine kinases, and small GTPases failed to interact with the cytoskeleton in agonist-stimulated MYH9-RD platelets. These results demonstrate for the first time that mutations of MYH9 result in an alteration of the composition and agonist-induced reorganization of the platelet cytoskeleton. We suggest that these abnormalities may represent the biochemical basis for the previously reported functional alterations of MYH9-RD platelets, and for the abnormal platelet formation from megakaryocytes, resulting in thrombocytopenia and giant platelets.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15869600     DOI: 10.1111/j.1538-7836.2005.01244.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  12 in total

1.  Myosin-II repression favors pre/proplatelets but shear activation generates platelets and fails in macrothrombocytopenia.

Authors:  Kyle R Spinler; Jae-Won Shin; Michele P Lambert; Dennis E Discher
Journal:  Blood       Date:  2014-11-13       Impact factor: 22.113

Review 2.  The biogenesis of platelets from megakaryocyte proplatelets.

Authors:  Sunita R Patel; John H Hartwig; Joseph E Italiano
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

3.  Phosphoglycerol dihydroceramide, a distinctive ceramide produced by Porphyromonas gingivalis, promotes RANKL-induced osteoclastogenesis by acting on non-muscle myosin II-A (Myh9), an osteoclast cell fusion regulatory factor.

Authors:  Hiroyuki Kanzaki; Alexandru Movila; Rayyan Kayal; Marcelo H Napimoga; Kenji Egashira; Floyd Dewhirst; Hajime Sasaki; Mohammed Howait; Ayman Al-Dharrab; Abdulghani Mira; Xiaozhe Han; Martin A Taubman; Frank C Nichols; Toshihisa Kawai
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2017-01-31       Impact factor: 4.698

4.  Megakaryocyte migration defects due to nonmuscle myosin IIA mutations underlie thrombocytopenia in MYH9-related disease.

Authors:  Kasturi Pal; Roberta Nowak; Neil Billington; Rong Liu; Arit Ghosh; James R Sellers; Velia M Fowler
Journal:  Blood       Date:  2020-05-21       Impact factor: 22.113

Review 5.  Of mice and men: Relevance of cellular and molecular characterizations of myosin IIA to MYH9-related human disease.

Authors:  Sharona Even-Ram; Kenneth M Yamada
Journal:  Cell Adh Migr       Date:  2007-07-26       Impact factor: 3.405

Review 6.  Non-muscle myosin II takes centre stage in cell adhesion and migration.

Authors:  Miguel Vicente-Manzanares; Xuefei Ma; Robert S Adelstein; Alan Rick Horwitz
Journal:  Nat Rev Mol Cell Biol       Date:  2009-11       Impact factor: 94.444

7.  MYH9-related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype-phenotype correlations.

Authors:  Alessandro Pecci; Catherine Klersy; Paolo Gresele; Kieran J D Lee; Daniela De Rocco; Valeria Bozzi; Giovanna Russo; Paula G Heller; Giuseppe Loffredo; Matthias Ballmaier; Fabrizio Fabris; Eloise Beggiato; Walter H A Kahr; Nuria Pujol-Moix; Helen Platokouki; Christel Van Geet; Patrizia Noris; Preethi Yerram; Cedric Hermans; Bernhard Gerber; Marina Economou; Marco De Groot; Barbara Zieger; Erica De Candia; Vincenzo Fraticelli; Rogier Kersseboom; Giorgina B Piccoli; Stefanie Zimmermann; Tiziana Fierro; Ana C Glembotsky; Fabrizio Vianello; Carlo Zaninetti; Elena Nicchia; Christiane Güthner; Carlo Baronci; Marco Seri; Peter J Knight; Carlo L Balduini; Anna Savoia
Journal:  Hum Mutat       Date:  2013-12-12       Impact factor: 4.878

8.  Mlck1a is expressed in zebrafish thrombocytes and is an essential component of thrombus formation.

Authors:  E Tournoij; G J Weber; J W N Akkerman; P G de Groot; L I Zon; F L Moll; S Schulte-Merker
Journal:  J Thromb Haemost       Date:  2009-12-11       Impact factor: 5.824

9.  Cytoskeletal perturbation leads to platelet dysfunction and thrombocytopenia in variant forms of Glanzmann thrombasthenia.

Authors:  Loredana Bury; Emanuela Falcinelli; Davide Chiasserini; Timothy A Springer; Joseph E Italiano; Paolo Gresele
Journal:  Haematologica       Date:  2015-10-09       Impact factor: 9.941

Review 10.  What's new in using platelet research? To unravel thrombopathies and other human disorders.

Authors:  Kathleen Freson; Veerle Labarque; Chantal Thys; Christine Wittevrongel; Chris Van Geet
Journal:  Eur J Pediatr       Date:  2007-07-10       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.